Current Capabilities
State-of-the-Art EU, GMP facility
Encapsulation for primary and secondary packaging of solid dosage forms.
Capacity: 20 MM finished pack per year.
Secondary packaging of injectable oncology products, beta lactams and steroids in dedicated space. Separated from main manufacturing area.
Located in Belgrade, built in 2005 operations started in 2006.
EU GMP approval obtained in June 2007, renewed in June 2010.
ü Supply base due to increasing demand for PharmaSwiss products for sales in Serbia 2006, and for other PharmaSwiss markets from 2009.
ü Logistic flexibility for small volume and special PharmaSwiss products
PharmaSwiss – Regional Leader in Solid Dosage Forms
Greenfield investment, located in Belgrade.
Project started in Q4 2009. Site purchased in 2009. Ground-breaking scheduled for Spring, 2011, start of operations planned for 2012.
Production of solid dosage forms, tablets and capsules: weighing, granulation, blending, tablet pressing, coating, encapsulation and blister packaging.
Projected capacity: 1 billion bulk units / 50 MM finished packs per year.
Secondary packaging of oncology products, beta lactams and steroids in dedicated space. Separated from main manufacturing area.
R&D department for development and up-scaling.
QC with own laboratory.
Warehouse with logistic centre.
ü Qualifies for treatment under Serbian reimbursement as “domestic product”.
ü Assures earlier launch of new products.
ü Improves control and flexibility in supply chain.
ü Improves cost structure.
ü Enables enhanced competitiveness for PharmaSwiss brands in longer term period.